Levocetirizin Krka (Levocetirizine Dihydrochloride)

Levocetirizine Dihydrochloride works by selectively blocking peripheral H1 histamine receptors. This inhibition prevents histamine from binding to its receptors on blood vessels and sensory nerves, thereby reducing vasodilation, increased permeability, and nerve stimulation that cause typical allergy symptoms such as itching, swelling, and nasal discharge.

The appropriate dose of Levocetirizin Krka is determined by the prescribing healthcare professional based on the patient’s age, weight, renal function, and severity of symptoms. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for levocetirizine during pregnancy are limited, so pregnant women should only use the product if the potential benefit outweighs any risk and after consulting their physician. While it is excreted in breast milk in small amounts, nursing mothers should discuss use with a healthcare provider to assess safety for the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Levocetirizin Krka is a second‑generation H1 antagonist, offering effective allergy relief with a lower propensity for sedation compared with first‑generation antihistamines such as diphenhydramine. Compared with other second‑generation agents like cetirizine, it provides similar efficacy but may have a slightly faster onset and reduced central nervous system penetration.

Store Levocetirizin Krka at ambient temperature below 25 °C. Keep the tablets in their original blister pack, protect them from moisture and direct light, and ensure the container is tightly closed to maintain product stability throughout its shelf life.

Levocetirizin Krka is taken orally, usually with a glass of water. The tablet should be swallowed whole and can be taken with or without food, according to the prescriber’s guidance. Patients should avoid crushing or chewing the tablet unless specifically instructed.

The most serious adverse reactions, although rare, include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, and anaphylaxis. Any signs of swelling of the face, lips, tongue, or difficulty breathing require immediate medical attention.

Levocetirizin Krka should be avoided in individuals with known hypersensitivity to levocetirizine or any of the excipients in the tablet. Caution is also advised for patients with severe renal impairment, pregnant or nursing women without medical supervision, and those taking interacting medications that could increase sedation or drug levels.